© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 24, 2073-2075,
December 15, 1999
© 1999 Oxford University Press
NEWS |
Cancer Treatment And Vitamin C: The Debate Lingers
In the 1980s, Nobel laureate Linus Pauling, Ph.D., and researchers at the Mayo Clinic and Mayo Foundation in Rochester, Minn., clashed publicly over the merits of vitamin C in treating cancer. While Pauling maintained that terminal cancer patients who took vitamin C daily lived three to four times longer than patients who did not take vitamin C supplements, Mayo researchers in three studies concluded that vitamin C supplementation had no advantage over placebo therapy.
|
Fifteen years later, vitamin C continues to stir controversy. But the focus now is not whether vitamin C alone brings a survival edge, but whether it bolsters or undermines many standard cancer therapies.
In one camp are physicians like David Golde, M.D., physician-in-chief
of Memorial Sloan-Kettering Cancer Center,
Logic vs. Data
The Fenton Reaction
Wait and "C"
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Ohtani, A. Iwamaru, W. Deng, K. Ueda, G. Wu, G. Jayachandran, S. Kondo, E. N. Atkinson, J. D. Minna, J. A. Roth, et al. Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non-Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy Cancer Res., July 1, 2007; 67(13): 6293 - 6303. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zou, P. Yue, N. Lin, M. He, Z. Zhou, S. Lonial, F. R. Khuri, B. Wang, and S.-Y. Sun Vitamin C Inactivates the Proteasome Inhibitor PS-341 in Human Cancer Cells Clin. Cancer Res., January 1, 2006; 12(1): 273 - 280. [Abstract] [Full Text] [PDF] |
||||


